Biohaven Announces Pricing Of $200 Million Public Offering Of Common Shares

Retrieved on: 2021-03-16 02:15:00

Tags for this article:

Finance

Financial economics

Initial public offering

Money

Financial markets

Stock market

U.S. Securities and Exchange Commission

Biohaven Pharmaceutical Holding Company Ltd.

Click the tags to see associated articles and topics

Biohaven Announces Pricing Of $200 Million Public Offering Of Common Shares. View article details on hiswai:

Excerpt

Goldman Sachs & Co. LLC is acting as the book-running manager of the offering. The offering is being made only by means of a prospectus supplement ...

Article found on: www.prnewswire.com

View Original Article